Multiplex Assay Kit for Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay)

Fib2; FG-A; FGA; Fibrinopeptide A

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-102 99
EDTA plasma(n=5) 80-90 82
heparin plasma(n=5) 92-99 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-105% 84-101% 87-96% 97-104%
EDTA plasma(n=5) 86-101% 89-101% 86-94% 95-103%
heparin plasma(n=5) 81-101% 83-97% 85-92% 86-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FGA) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis PubMed: 25789864
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer y2016:0077095.html
GLYCOCONJUGATE JOURNAL Nattokinase-heparin exhibits beneficial efficacy and safety—an optimal strategy for CKD patients on hemodialysis Pubmed: 30788657
Proteomics Clinical Applications Comparative proteomics analysis of serum proteins in gestational diabetes during early and middle stages of pregnancy Pubmed: 31162828
Reproductive BioMedicine Online Fibrinogen alpha chain is upregulated and affects the pathogenesis of endometriosis
Redox Biology Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced … Pubmed: 32193146
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB154Hu02 Recombinant Fibrinogen Alpha Chain (FGA) Positive Control; Immunogen; SDS-PAGE; WB.
RPB154Hu01 Recombinant Fibrinogen Alpha Chain (FGA) Positive Control; Immunogen; SDS-PAGE; WB.
PAB154Hu01 Polyclonal Antibody to Fibrinogen Alpha Chain (FGA) WB; ICC; IHC-P; IHC-F; ELISA.
FAB154Hu01 Anti-Fibrinogen Alpha Chain (FGA) Polyclonal Antibody Flow cytometry.
LAB154Hu71 Biotin-Linked Polyclonal Antibody to Fibrinogen Alpha Chain (FGA) WB; IHC; ICC.
LAB154Hu81 FITC-Linked Polyclonal Antibody to Fibrinogen Alpha Chain (FGA) WB; IHC; ICC; IF.
MAB154Hu22 Monoclonal Antibody to Fibrinogen Alpha Chain (FGA) WB; IHC; ICC; IP.
SEB154Hu ELISA Kit for Fibrinogen Alpha Chain (FGA) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB154Hu Multiplex Assay Kit for Fibrinogen Alpha Chain (FGA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.